Device Authority expands enterprise reach through IoT security partnership

Tern plc

Device Authority has strengthened its enterprise positioning through a strategic partnership with Xalient, a provider of identity-led cybersecurity services and managed solutions. The collaboration will see Xalient integrate Device Authority’s KeyScaler platform into its IoT security offering, with the aim of helping enterprise customers protect connected devices across complex IT, IoT and operational technology environments.

This places Device Authority’s technology within a managed security model that is designed for large organisations facing rising operational, regulatory and cyber risk. As connected devices become more embedded in sectors such as energy, utilities, manufacturing, healthcare and critical infrastructure, enterprises are under pressure to secure assets that are often distributed, long-lived and difficult to manage through traditional security tools.

The partnership addresses a practical challenge for customers: manual approaches to device identity, credential management and access control are increasingly difficult to scale. In large deployments, unmanaged or poorly governed devices can create visibility gaps, compliance issues and operational exposure. Device Authority’s KeyScaler platform is designed to automate identity lifecycle management for IoT and OT devices, from secure onboarding and credential provisioning through to certificate rotation, decommissioning and policy-driven access control.

Xalient’s role adds an important route-to-market dimension. By delivering the joint capability through its managed “as-a-service” security model, Xalient can support customers that want to improve IoT and OT security without adding complexity to internal teams.

Tern plc (LON:TERN) backs exciting, high growth IoT innovators in Europe. They provide support and create a genuinely collaborative environment for talented, well-motivated teams.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Novo Nordisk deal puts focus on next generation of oral GLP-1 treatments

Novo Nordisk secures rights to Hengrui's investigational HRS-1596 in a potential $2.6bn deal, targeting the development of once-weekly oral...

Device Authority warns supermarket freezer cyberattack exposes connected device security risks

Device Authority warns that a cyberattack affecting around 700 French supermarkets exposes security weaknesses in connected industrial equipment and...

Breast cancer research highlights importance of patient intelligence in pharma

Talking Medicines highlights how AI-powered patient intelligence can help pharmaceutical companies understand breast cancer treatment experiences and identify unmet...

GLP-1 drugs linked to emerging research into mental health and addiction

Research into GLP-1 medicines is expanding beyond weight loss, with studies examining potential links to depression, cognitive function, alcohol...

Talking Medicines examines emerging links between GLP-1 drugs and mental health

Researchers are investigating the potential links between GLP-1 medicines and mental health, with early findings prompting further studies into...

Tern invests £78,000 in Device Authority through 8% convertible loan notes

Tern Plc has committed approximately £78,000 to new convertible loan notes issued by Device Authority, which carry 8% annual...

Search